|
Volumn 12, Issue 2, 2002, Pages 133-139
|
In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations - A potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases
|
Author keywords
Antibodies; Infections; Intravenous immunoglobulins
|
Indexed keywords
IMMUNOGLOBULIN;
IMMUNOGLOBULIN G;
OMR IGG AM;
BACTERIUM ANTIBODY;
VIRUS ANTIBODY;
ADENOVIRUS;
ANTIBACTERIAL ACTIVITY;
ANTIVIRAL ACTIVITY;
ARTICLE;
CHLAMYDOPHILA PNEUMONIAE;
EPSTEIN BARR VIRUS;
HELICOBACTER PYLORI;
HERPES SIMPLEX VIRUS 1;
HERPES SIMPLEX VIRUS 2;
HUMAN HERPESVIRUS 6;
HUMAN HERPESVIRUS 7;
IMMUNOTHERAPY;
IN VITRO STUDY;
INFECTION;
MEASLES VIRUS;
MUMPS VIRUS;
MYCOPLASMA PNEUMONIAE;
NONHUMAN;
PARVOVIRUS;
RUBELLA VIRUS;
ST LOUIS FLAVIVIRUS;
TETANUS;
VARICELLA ZOSTER VIRUS;
ANIMAL;
BACTERIUM;
COMMUNICABLE DISEASE;
DRUG EFFECT;
FUNGUS;
HUMAN;
IMMUNOLOGY;
MICROBIOLOGICAL EXAMINATION;
PARASITE;
STANDARD;
ANIMALS;
ANTIBODIES, BACTERIAL;
ANTIBODIES, VIRAL;
BACTERIA;
COMMUNICABLE DISEASES;
FUNGI;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
MICROBIAL SENSITIVITY TESTS;
PARASITES;
|
EID: 0036228218
PISSN: 09587578
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-3148.2002.00360.x Document Type: Article |
Times cited : (102)
|
References (35)
|